4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
MRI IN JIA
5TH NATIONAL CONFERENCE OF PEDIATRIC RHEUMATOLOGY, KOLKATA, 29TH & 30TH SEPTEMBER 2007

Anup Sadhu
Consultant Radiologist
EKO CT & MRI Scan Centre
Medical College, Kolkata


MRI is one of the important modalities in musculoskeletal disorders.

For orthopaedic surgeons MRI is " God's gift". MRI has significantly advanced our understanding of the early pathology of RA. One of the possible practical applications of MRI in early RA is to help differentiate this condition from other inflammatory arthropathies. Bone marrow oedema at the articular margin was found to be a useful differentiating feature being present in approximately 60% of patients with poor prognosis (insidious onset). Intrasynovial inflammation may characterize those with poor prognosis and extrasynovial capsular inflammation may be a marker of good prognosis associated with remission. MRI is an exciting imaging modality and is particularly suitable for application to musculoskeletal medicine.

Scoring systems have been developed in MRI analogous to the radiological scoring and are being standardised so that they can be used universally to measure joint inflammation and damage. MRI has clinical application in the diagnosis of inflammatory arthritis and in the prediction of prognosis which could influence management decisions in early disease. It is also likely to assume crucial importance in monitoring response to disease-modifying agent so that efficacy can be assessed within weeks of starting therapy.

MRI is unlikely to replace plain radiography as this remains a better tool for imaging multiple joint areas in established disease. However, MRI is emerging as an important imaging technique in the context of early arthritis and promises to be a useful addition to the radiologist's armamentarium.


Last Updated on 15-12-2007

How to cite this url
5th National Conference of Pediatric Rheumatology - Conference Abstracts. Pediatric Oncall [serial online] 2007 [cited 15 December 2007(Supplement 12)];4. Available from:
http://www.pediatriconcall.com/fordoctor/Conference_abstracts/ncpr/
mri_jia.asp
 
 
 
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us